Day: September 6, 2023

After nearly seven years at Novartis and more than four years as a member of the ECN, Ms. Tschudin will pursue her next chapter of leadership outside of NovartisDr. Horber to drive next phase of international growth, shape commercial strategy, and continue Novartis leadership in reimagining medicines for patients around the worldBasel, September 06, 2023 — Novartis today announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the Executive Committee of Novartis (ECN), effective September 15, after nearly seven years of commercial leadership at Novartis. Patrick Horber, M.D., currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year, reporting...

Aalst, Belgium, September 6, 2023 – Ontex Group NV (“Ontex” or, the “Company”), a leading international provider of personal hygiene solutions, announces today that Peter Vanneste, Chief Financial Officer at Ontex, has decided to leave Ontex early October 2023, to pursue a career opportunity outside the Group. His successor will be announced in due time. In the interim the responsibilities of CFO will be assumed by Gustavo Calvo Paz, CEO. Gustavo Calvo Paz, CEO, stated: “We recognize the contribution that Peter Vanneste has made, shaping and executing Ontex’ strategic transformation, including refocusing with successful divestments. He also contributed to guiding the company through the difficult macro-economic conditions with a clear focus on the Group’s financial health and organization. This allowed Ontex to gradually restore profitable...

HOUSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2023. As of August 31, 2023, the Fund’s net assets were $412.1 million and its net asset value per share was $8.73. As of August 31, 2023, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 746% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 469%.     Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesAugust 31, 2023(Unaudited)    (in...

HOUSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2023. As of August 31, 2023, the Company’s net assets were $1.4 billion, and its net asset value per share was $10.22. As of August 31, 2023, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 592% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 434%.Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesAugust 31, 2023(Unaudited)    (in...

Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury, today announced that it will host a webcast to discuss its Half Year 2023 business highlights. The webcast will be held on September 19, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Lara Smith Weber, who will discuss highlights from Half Year 2023 and provide a business update. To join the webcast via Zoom, please register using this link. Participants may also join by phone: +32 2 290 9360 (Belgium)+49 69 3807 9884 (Germany)+31 20 794 0854 (Netherlands)+41 22 591 0156 (Switzerland)+44 203 481 5240 (United Kingdom)+1 346 248 7799 (US) Additional telephone numbers available Webinar...